RNAi and CRISPR/Cas9 based in vivo models for drug discovery

被引：0
|
作者：
Premsrirut, Prem K.
Martin, Gregory
Dow, Lukas
Kim, Sang Yong
Zuber, Johannes
Lowe, Scott
Hannon, Greg
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4188
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4188
引用
收藏
页数：2
相关论文
共 50 条
  • [1] RNAi and CRISPR/Cas9 based in vivo models for drug discovery
    Premsrirut, Prem
    Martin, Gregory
    Dow, Lukas
    Kim, Sang Yong
    Zuber, Johannes
    Lowe, Scott
    Hannon, Greg
    TRANSGENIC RESEARCH, 2016, 25 (02) : 218 - 218
  • [2] RNAi and CRISPR/Cas9 Based In Vivo Models for Drug Discovery
    Premsrirut, Prem
    Wang, Chia-Lin
    Yang, Yu-ting
    Fellmann, Christof
    Dow, Lukas
    Zuber, Johannes
    Lowe, Scott
    Pesic, Marina
    Wolter, Katharina
    Zender, Lars
    BLOOD, 2017, 130
  • [3] RNAi and CRISPR/Cas9 based in vivo models for drug discovery
    Premsrirut, P.
    Martin, G.
    Dow, L.
    Kim, S. Y.
    Zuber, J.
    Hannon, G.
    Lowe, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S208 - S208
  • [4] RNAi and CRISPR/Cas9-based in vivo models for drug discovery
    Premsrirut, Prem K.
    Fellmann, Christof
    CANCER RESEARCH, 2015, 75
  • [5] RNAi and CRISPR/Cas9-based in vivo models for drug discovery.
    Premsrirut, Prem K.
    Wang, Chia-Lin
    Yang, Yu-Ting
    Pelossof, Rafii
    Leslie, Christina
    Fellmann, Christof
    Dow, Lukas
    Zuber, Johannes
    Lowe, Scott
    CANCER RESEARCH, 2018, 78 (10) : 73 - 73
  • [6] CRISPR/Cas9-based development of RNAi rat models for drug discovery
    Premsrirut, Prem K.
    Wang, Chia-Lin
    Yang, Yu-Ting
    Dow, Lukas E.
    Zuber, Johannes
    Lowe, Scott W.
    CANCER RESEARCH, 2018, 78 (13)
  • [7] CRISPR/Cas9 library screening for drug target discovery
    Kurata, Morito
    Yamamoto, Kouhei
    Moriarity, Branden S.
    Kitagawa, Masanobu
    Largaespada, David A.
    JOURNAL OF HUMAN GENETICS, 2018, 63 (02) : 179 - 186
  • [8] CRISPR/Cas9 Editing to Facilitate and Expand Drug Discovery
    Robert, Francis
    Huang, Sidong
    Pelletier, Jerry
    CURRENT GENE THERAPY, 2017, 17 (04) : 275 - 285
  • [9] CRISPR/Cas9 library screening for drug target discovery
    Morito Kurata
    Kouhei Yamamoto
    Branden S. Moriarity
    Masanobu Kitagawa
    David A. Largaespada
    Journal of Human Genetics, 2018, 63 : 179 - 186
  • [10] Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery
    Ahmad, Gulzar
    Amiji, Mansoor
    DRUG DISCOVERY TODAY, 2018, 23 (03) : 519 - 533
12345